Notfälle
Blutspende
Karriere
Presse
Forschung
Lehre
Patienten
Zuweiser

Zeitschriften- und Buchbeiträge

Buchbeiträge:

Heat Shock Proteins in Renal Cell Carcinoma, Derek Atkins, Rudolf Lichtenfels and Barbara Seliger; Karger (2005)

 

Identification of diagnostic biomarkers for tumors by proteome analysis in Methods, Cancers and Perspectives of Pre-symptomatic Tumor Diagnostics; Barbara Seliger, Karger (2005)

 

Phänotypisierung von Tumorzellen; Barbara Seliger, Karger (2005) 

 

Biomarker discovery in renal cell carcinoma applying proteome-based studies in combination with serology; Barbara Seliger and Roland Kellner, Wiley (2006)

 

Humoral antigens in cancer: Serological identification methods, Part II: Proteomex and AMIDA; Olivier Gires und Barbara Seliger, CCG Molecular Oncology (2007)

 

Potential immune escape mechanisms of tumors: MHC class I molecules – enemies or friends; Barbara Seliger, Springer (2008)

 

Renal and urinary proteomics: Methods and Protocols; Barbara Seliger, Rudolf Lichtenfels, Maja Baumgaertner, Christian Recktenwald and Sven Dressler, Wiley (October 2009)

 

Tumor-associated antigens; Edited by Olivier Gires und Barbara Seliger, Wiley (2009)

 

PROTEOMEX Analysis of Renal Cell Carcinoma; Rudolf Lichtenfels und Barbara Seliger, Wiley (2009)

 

The non-classical antigens of HLA-G and HLA-E as diagnostic and prognostic biomarkers and as therapeutic targets in transplantation and tumors; Barbara Seliger, Clinical Transplants, Terasaki Foundation Laboratory, Los Angeles, California (2013)

 

B7-H Abnormalities in Melanoma and Clinical Relevance; Barbara Seliger, Springer (2013)

 

Role of the Non-classical HLA class I Antigens for Immune Escape; Barbara Seliger und Simon Jasinski-Bergner, Springer (2015)

 

The Role of Immune Modulatory MicroRNAs in Tumors; Barbara Seliger, Anne Meinhardt und Dörte Falke, InTech (2016)

 

Zeitschriftenbeiträge:

Molekulare Diagnostik bei soliden Tumoren; Frank Bartel, Udo Siebolts, Claudia Wickenhauser, Barbara Seliger; BioSpektrum, Ausgabe 7/2014, Springer (2014)

 

Die Zukunft der Immuntherapie in Tumoren. Zeitschrift "Leben"; Jahrgang 16, Ausgabe 01/2016, Krebsgesellschaft Sachsen-Anhalt, ISSN 1864-7804